Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Cellectis S.A. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −6 vs. Q4 2022
- Shares held
- 15.2M
- +6.47M (+74.1%) vs. Q4 2022
- Total value
- $29.3M
- +$11.0M (+59.7%) vs. Q4 2022
- New holders
- 6
- 11 more added
- Sold out
- 12
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $0 | 0.00% | +31 | New |
| EverSource Wealth Advisors, LLC | 13 | $25 | 0.00% | +13 | New |
| Barclays PLC | 28 | $54 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 330 | $637 | 0.00% | −5,117−93.9% | Reduced |
| TD Waterhouse Canada Inc. | 360 | $720 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,341 | $3.00K | 0.00% | −257−16.1% | Reduced |
| Assetmark, Inc | 1,911 | $3.69K | 0.00% | +391+25.7% | Added |
| BlackRock Inc. | 2,755 | $5.32K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $6.95K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,210 | $12.0K | 0.00% | −27−0.4% | Reduced |
| Bank of America Corp | 9,155 | $17.7K | 0.00% | +2,036+28.6% | Added |
| Geode Capital Management, LLC | 10,776 | $20.8K | 0.00% | 00.0% | Unchanged |
| One68 Global Capital, LLC | 11,000 | $21.2K | 0.03% | +11,000 | New |
| LPL Financial LLC | 12,357 | $23.8K | 0.00% | +12,357 | New |
| Wells Fargo & Company | 16,479 | $31.8K | 0.00% | −500−2.9% | Reduced |
| Envestnet Asset Management Inc | 42,868 | $37.0K | 0.00% | −14,579−25.4% | Reduced |
| Old Mission Capital LLC | 22,329 | $43.1K | 0.00% | +10,577+90.0% | Added |
| Vontobel Holding Ltd. | 30,000 | $57.9K | 0.00% | +16,000+114.3% | Added |
| Jane Street Group, LLC | 50,522 | $99.8K | 0.00% | −160,945−76.1% | Reduced |
| Morgan Stanley | 77,702 | $150.0K | 0.00% | +3,561+4.8% | Added |
| Oppenheimer & Co Inc | 116,163 | $224.2K | 0.00% | +41,111+54.8% | Added |
| D. E. Shaw & Co., Inc. | 122,530 | $236.5K | 0.00% | −104,582−46.0% | Reduced |
| CVI Holdings, LLC | 129,434 | $249.8K | 0.09% | +129,434 | New |
| KBC Group NV | 163,447 | $315.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $438.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 1,180,059 | $2.28M | 0.00% | +500,093+73.5% | Added |
| Principal Financial Group Inc | 1,361,860 | $2.63M | 0.00% | +27,810+2.1% | Added |
| Credit Suisse AG | 1,438,255 | $2.78M | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 1,639,896 | $3.16M | 0.00% | +1,040,000+173.4% | Added |
| Capital International Investors | 1,848,804 | $3.57M | 0.00% | +1,400,000+311.9% | Added |
| Bpifrance SA | 2,186,960 | $4.22M | 0.11% | +2,186,960 | New |
| Long Focus Capital Management, LLC | 4,487,293 | $8.66M | 1.40% | +1,803,660+67.2% | Added |
| Sofos Investments, Inc. | 2 | – | – | 00.0% | Unchanged |
| Capital World Investors | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −58,207−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −58,087−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −26,362−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −19,365−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −18,208−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |